Pharmaniaga Bhd (KLSE:7081) — Stock Price

RM1.17 MYR
▼ -0.85% today

Pharmaniaga Bhd (KLSE:7081) is currently trading at RM1.17 MYR, down 0.85% today. Over the past 52 weeks, shares have ranged between RM0.17 and RM1.38. This page tracks Pharmaniaga Bhd's live share price on the KLSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Pharmaniaga Bhd market cap and net worth.

Pharmaniaga Bhd (7081) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Pharmaniaga Bhd's daily closing share price and trading volume on the KLSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Pharmaniaga Bhd Income Statement — Revenue, Profit & Earnings by Year

Pharmaniaga Bhd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue RM3.93 Billion RM3.76 Billion RM3.40 Billion RM3.48 Billion RM4.82 Billion
Cost of Revenue RM3.52 Billion RM3.22 Billion RM3.10 Billion RM3.69 Billion RM4.18 Billion
Gross Profit RM409.16 Million RM540.49 Million RM307.82 Million RM-209.59 Million RM630.01 Million
Research & Development — RM8.63 Million RM5.25 Million RM10.23 Million RM5.21 Million
SG&A — RM279.57 Million RM328.27 Million RM314.72 Million RM322.64 Million
Total Operating Expenses RM279.51 Million RM262.49 Million RM307.82 Million RM314.38 Million RM322.30 Million
Operating Income RM129.65 Million RM278.01 Million RM694.00K RM-520.33 Million RM310.33 Million
EBITDA RM168.94 Million RM288.49 Million RM-16.32 Million RM-542.93 Million RM335.28 Million
EBIT RM129.65 Million RM260.93 Million RM694.00K RM-570.55 Million RM307.37 Million
Interest Expense RM61.34 Million RM71.97 Million RM61.84 Million RM40.04 Million RM33.32 Million
Income Before Tax RM74.74 Million RM194.18 Million RM-78.16 Million RM-610.59 Million RM277.07 Million
Income Tax Expense RM24.05 Million RM60.39 Million RM581.00K RM17.07 Million RM104.87 Million
Net Income RM48.51 Million RM131.82 Million RM-80.16 Million RM-629.92 Million RM172.15 Million

Pharmaniaga Bhd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Pharmaniaga Bhd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets RM2.25 Billion RM1.99 Billion RM1.91 Billion RM1.85 Billion RM2.26 Billion
Total Current Assets RM1.46 Billion RM1.20 Billion RM1.11 Billion RM1.19 Billion RM1.62 Billion
Cash & Equivalents — — — — —
Short-term Investments RM147.98 Million RM8.57 Million RM2.87 Million RM4.11 Million RM10.25 Million
Net Receivables RM446.69 Million RM407.51 Million RM285.22 Million RM261.75 Million RM227.85 Million
Inventory RM729.82 Million RM612.79 Million RM580.64 Million RM767.26 Million RM1.26 Billion
Property, Plant & Equipment RM602.78 Million RM609.36 Million RM605.75 Million RM443.03 Million RM395.59 Million
Goodwill RM77.03 Million RM77.31 Million RM77.47 Million RM77.34 Million RM129.47 Million
Total Liabilities RM1.79 Billion RM2.14 Billion RM2.19 Billion RM2.20 Billion RM1.79 Billion
Total Current Liabilities RM1.61 Billion RM1.95 Billion RM2.00 Billion RM2.07 Billion RM1.47 Billion
Long-term Debt RM125.40 Million RM129.57 Million RM138.62 Million RM189.67 Million RM284.99 Million
Net Debt RM709.44 Million RM1.04 Billion RM1.06 Billion RM1.12 Billion RM804.50 Million
Total Stockholder Equity RM434.47 Million RM-171.28 Million RM-299.07 Million RM-369.69 Million RM450.46 Million
Retained Earnings RM97.06 Million RM-471.41 Million RM-603.42 Million RM-525.23 Million RM293.73 Million

Pharmaniaga Bhd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Pharmaniaga Bhd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow RM-17.69 Million RM42.67 Million RM46.95 Million RM-142.34 Million RM-64.06 Million
Capital Expenditures RM29.78 Million RM31.16 Million RM73.66 Million RM77.64 Million RM45.36 Million
Free Cash Flow RM-47.47 Million RM11.51 Million RM-26.71 Million RM-219.97 Million RM-109.41 Million
Investing Cash Flow RM-180.24 Million RM-45.62 Million RM-67.93 Million RM-72.33 Million RM-45.56 Million
Financing Cash Flow RM164.62 Million RM22.10 Million RM95.27 Million RM220.79 Million RM120.74 Million
Dividends Paid — RM0.00 RM-7.86 Million RM-82.53 Million RM58.95 Million
Stock-Based Compensation — — — RM2.09 Million RM1.73 Million
Depreciation RM39.30 Million RM41.38 Million RM38.77 Million RM34.02 Million RM31.70 Million
Change in Cash RM-35.48 Million RM18.64 Million RM74.59 Million RM5.74 Million RM11.25 Million

Pharmaniaga Bhd Earnings History — EPS Actual vs. Analyst Estimates

Track Pharmaniaga Bhd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 18, 2026 0.02 — —
Feb 26, 2026 0.00 — —
Nov 24, 2025 0.00 — —
Aug 19, 2025 0.00 — —
May 16, 2025 0.06 — —
Feb 28, 2025 0.00 — —
Nov 26, 2024 0.07 — —
Aug 21, 2024 0.00 — —